Jun 2026 (Q4 FY26) — Jul 29, 2026
Procter & Gamble Q4 FY26 — Stabilized Share & Strategic Interventions Drive Momentum
Read the full callProcter & Gamble (PG) earnings
- Jun 2026
- Jun 2026 (Q4 FY26)
- Jun 2026
Procter & Gamble earnings: last reported Wed, 29 Jul 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 21,203 | +1.5% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 18.6 | −2.2 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 3,045 | −15.8% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Guidance
What management said, and what became of it
17 of 18 judged targets kept · 24 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Fiscal 2026 adjusted free cash flow productivity | 85% to 90% | Jun 2025 | Adjusted free cash flow productivity was 100% | Achieved |
| First quarter fiscal 2027 core EPS growth | down 5% or more versus prior year | Jun 2026 | we estimate the cost dynamic will cause Q1 EPS to be down 5% or more versus prior year | New |
1 of PROCTER & GAMBLE Co's 42 targets was missed. See which ones, and which are quietly gone. The 2 above are the free sample; 40 more targets are in the full ledger.
Claimed
- Global market share stabilized, exiting FY26 flat, with trends improving in the second half.
- E-commerce sales increased 6% in FY26, now representing 20% of total company sales.
- Adjusted free cash flow productivity was 100% for FY26 and 133% for Q4 FY26.
- Returned over $15 billion of value to shareholders in FY26, comprising over $10 billion in dividends and $5 billion in share repurchases.
- Greater China organic sales grew 4% in Q4 and FY26, showing positive momentum.
Qualified
- Q4 FY26 core EPS was $1.43, down 3% versus prior year, and currency-neutral core EPS decreased 5%.
- Q4 FY26 core operating margin decreased 130 basis points.
- Q4 FY26 organic sales rounded down to in line with prior year, impacted by U.S. trade dynamics and a spike in input costs.
- Expected cost headwind of approximately $1 billion after tax for FY27, driven by higher raw materials, energy, and transportation.
- Q1 FY27 EPS is estimated to be down 5% or more versus prior year due to cost dynamics.
Price
$157.69 −1.04% · −$1.66
Performance +4.2% 1Y
1Y: $151.4 on 17 Oct 2025 → $157.69. High $167.2 (27 Feb 2026), low $138.04 (7 Jan 2026).
- Previous close
- $159.35
- 52-week range
- $138.04 – $167.2
- One year
- +3.77%
Overview
- Symbol
- PG
- Sector
- Consumer Staples
- Exchange
- US
- Currency
- USD
Guidance
What management said, and what became of it
17 of 18 judged targets kept · 24 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Fiscal 2026 adjusted free cash flow productivity | 85% to 90% | Jun 2025 | Adjusted free cash flow productivity was 100% | Achieved |
| First quarter fiscal 2027 core EPS growth | down 5% or more versus prior year | Jun 2026 | we estimate the cost dynamic will cause Q1 EPS to be down 5% or more versus prior year | New |
Claimed
- Global market share stabilized, exiting FY26 flat, with trends improving in the second half.
- E-commerce sales increased 6% in FY26, now representing 20% of total company sales.
- Adjusted free cash flow productivity was 100% for FY26 and 133% for Q4 FY26.
- Returned over $15 billion of value to shareholders in FY26, comprising over $10 billion in dividends and $5 billion in share repurchases.
- Greater China organic sales grew 4% in Q4 and FY26, showing positive momentum.
Qualified
- Q4 FY26 core EPS was $1.43, down 3% versus prior year, and currency-neutral core EPS decreased 5%.
- Q4 FY26 core operating margin decreased 130 basis points.
- Q4 FY26 organic sales rounded down to in line with prior year, impacted by U.S. trade dynamics and a spike in input costs.
- Expected cost headwind of approximately $1 billion after tax for FY27, driven by higher raw materials, energy, and transportation.
- Q1 FY27 EPS is estimated to be down 5% or more versus prior year due to cost dynamics.
The full ledger
Open PROCTER & GAMBLE Co’s full ledger
A free account opens 5 company ledgers a month. All 42 tracked commitments, with each call’s wording and source.
Call summaries
Mar 2026 (Q3 FY26) — Apr 24, 2026
Procter & Gamble Q3 FY26 — Solid Organic Sales Growth Amid Geopolitical Headwinds
Read the full callDec 2025 (Q2 FY26) — Jan 22, 2026
Procter & Gamble Q2 FY26 — Strategic Interventions Drive H2 Confidence Amidst Soft Q2
Read the full callEvery analysed call
Procter & Gamble earnings calls (PG)
Financials
What the filings say
Net profit, year on year: −16% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 21,737 | 21,882 | 19,776 | 20,889 | 22,386 | 22,208 | 21,235 | 21,203 |
| Operating profit | 5,797 | 5,741 | 4,558 | 4,355 | 5,856 | 5,366 | 4,576 | 3,950 |
| Operating margin | 26.7% | 26.2% | 23.1% | 20.9% | 26.2% | 24.2% | 21.6% | 18.6% |
| Interest | 238 | 240 | 217 | 212 | 197 | 220 | 223 | 237 |
| Net profit | 3,959 | 4,630 | 3,769 | 3,616 | 4,750 | 4,319 | 3,932 | 3,045 |
| EPS ($ per share) | 1.65 | 1.94 | 1.58 | — | 2 | 1.82 | 1.66 | — |
| Line item | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 4,009 | 4,009 | 4,009 | 4,009 | 4,009 | 4,009 | 4,009 | 4,009 |
| Reserves | 94,918 | 100,239 | 106,374 | 112,429 | 118,170 | 123,811 | 129,973 | 135,852 |
| Total liabilities | 67,516 | 73,822 | 72,653 | 70,354 | 73,764 | 71,811 | 72,946 | 72,210 |
| Fixed assets | 21,271 | 20,692 | 21,686 | 21,195 | 21,909 | 22,152 | 23,897 | 25,360 |
| Total assets | 115,095 | 120,700 | 119,307 | 117,208 | 120,829 | 122,370 | 125,231 | 126,521 |
| Line item | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 15,242 | 17,403 | 18,371 | 16,723 | 16,848 | 19,846 | 17,817 | 19,556 |
| Cash from investing | -3,490 | 3,045 | -2,834 | -4,424 | -3,500 | -3,504 | -3,818 | -4,624 |
| Cash from financing | -9,994 | -8,367 | -21,531 | -14,876 | -12,146 | -14,855 | -14,036 | -14,460 |
| Net cash flow | 1,670 | 11,942 | -5,893 | -3,074 | 1,032 | 1,235 | 75 | 386 |
| Capital expenditure | -3,347 | -3,073 | -2,787 | -3,156 | -3,062 | -3,322 | -3,773 | -4,409 |
| Free cash flow | 11,895 | 14,330 | 15,584 | 13,567 | 13,786 | 16,524 | 14,044 | 15,147 |
PG revenue by segment
| Segment | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 | Q4 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Fabric Home Care | 35% | 35% | 35% | 35% | 35% | 35% | 35% | 35% | +0.7% |
| Baby Feminine Family Care | 23% | 24% | 24% | 24% | 23% | 23% | 24% | 24% | -0.9% |
| Beauty | 18% | 18% | 18% | 18% | 19% | 18% | 18% | 19% | +6.5% |
| Health Care | 14% | 15% | 15% | 13% | 14% | 15% | 14% | 13% | +1.3% |
| Grooming | 8% | 8% | 8% | 8% | 8% | 8% | 8% | 8% | +1.0% |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
Insider filings
125 filings between Oct 30, 2025 and Oct 13, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$63.50M
32 sales by 15 insiders
Compensation
not trading decisions- 54
- Award — granted as compensation
- 17
- Option exercise — converted options into shares
- 20
- Tax withheld — shares kept back by the company to cover tax
Also filed: 2 gifts.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Moeller Jon R | — | $28.12M | Feb 12, 2026 |
| Pritchard Marc S. | — | $15.08M | Aug 20, 2026 |
| Coombe Gary A | — | $5.86M | Feb 12, 2026 |
| Aguilar Moses Victor Javier | — | $3.34M | Aug 20, 2026 |
| Purushothaman Balaji | — | $2.35M | Aug 20, 2026 |
| Whaley Susan Street | — | $2.20M | Oct 5, 2026 |
| Francisco Ma. Fatima | — | $2.18M | Feb 27, 2026 |
| Schulten Andre | — | $1.35M | Oct 5, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | Biggs M. Brett Director | Award | 1,438 | $0 |
| Oct 13, 2026 | McCarthy Christine M Director | Award | 1,438 | $0 |
| Oct 13, 2026 | Bonini Sheila Director | Award | 1,438 | $0 |
| Oct 13, 2026 | Subramaniam Rajesh Director | Award | 1,438 | $0 |
| Oct 13, 2026 | ARNOLD CRAIG Director | Award | 1,438 | $0 |
| Oct 13, 2026 | Chang Amy Director | Award | 1,438 | $0 |
| Oct 13, 2026 | JIMENEZ JOSEPH Director | Award | 1,438 | $0 |
| Oct 13, 2026 | Kempczinski Christopher J Director | Award | 1,438 | $0 |
| Oct 13, 2026 | Allen Bertrand Marc Director | Award | 1,438 | $0 |
| Oct 13, 2026 | Portman Robert Jones Director | Award | 1,438 | $0 |
| Oct 13, 2026 | McEvoy Ashley Director | Award | 1,438 | $0 |
| Oct 5, 2026 | Gama Paul CEO- Health Care | Sale | 2,225 | $323.4K |
| Oct 5, 2026 | Schulten Andre Chief Financial Officer | Sale | 3,914 | $568.9K |
| Oct 5, 2026 | Whaley Susan Street Chief Legal Officer & Secy | Sale | 2,369 | $344.3K |
| Oct 1, 2026 | Jejurikar Shailesh Chairman, President and CEO | Award | 16,065 | $0 |
| Oct 1, 2026 | Schulten Andre Chief Financial Officer | Award | 6,557 | $0 |
| Oct 1, 2026 | Santos de Azevedo Juliana Monteiro CEO - Grooming | Award | 3,130 | $0 |
| Oct 1, 2026 | Aguilar Moses Victor Javier Chf Rsch, Dev & Innov Officer | Award | 5,732 | $0 |
| Oct 1, 2026 | Whaley Susan Street Chief Legal Officer & Secy | Award | 6,110 | $0 |
| Oct 1, 2026 | Gama Paul CEO- Health Care | Award | 12,517 | $0 |
| Sep 8, 2026 | JIMENEZ JOSEPH Director | Award | 327 | $0 |
| Sep 8, 2026 | McEvoy Ashley Director | Award | 207 | $0 |
| Sep 8, 2026 | Portman Robert Jones Director | Award | 52 | $0 |
| Sep 8, 2026 | Kempczinski Christopher J Director | Award | 250 | $0 |
| Sep 8, 2026 | McCarthy Christine M Director | Award | 258 | $0 |
| Sep 8, 2026 | ARNOLD CRAIG Director | Award | 207 | $0 |
| Aug 24, 2026 | Janzaruk Matthew W. SVP - Chief Accounting Officer | Sale | 359 | $52.1K |
| Aug 21, 2026 | Raman Sundar G. CEO-Fabric Home & Habitat Care | Sale | 3,435 | $491.3K |
| Aug 20, 2026 | Aguilar Moses Victor Javier Chf Rsch, Dev & Innov Officer | Sale | 3,053 | $439.0K |
| Aug 20, 2026 | Pritchard Marc S. Chief Brand Officer | Sale | 4,030 | $579.5K |
| Aug 20, 2026 | Schulten Andre Chief Financial Officer | Sale | 5,402 | $776.8K |
| Aug 20, 2026 | Gama Paul CEO- Health Care | Sale | 3,396 | $488.3K |
| Aug 20, 2026 | Bharucha Freddy P. CEO - Beauty | Sale | 246 | $35.4K |
| Aug 20, 2026 | Abd El Hak Hesham CEO-Baby and Feminine Care | Sale | 1,936 | $278.4K |
| Aug 20, 2026 | Purushothaman Balaji Chief Human Resources Officer | Sale | 2,019 | $290.3K |
| Aug 20, 2026 | Santos de Azevedo Juliana Monteiro CEO - Grooming | Sale | 2,368 | $340.5K |
| Aug 20, 2026 | Jejurikar Shailesh Chairman, President and CEO | Sale | 6,176 | $888.0K |
| Aug 20, 2026 | Whaley Susan Street Chief Legal Officer & Secy | Sale | 2,238 | $321.8K |
| Aug 20, 2026 | Janzaruk Matthew W. SVP - Chief Accounting Officer | Sale | 156 | $22.4K |
| Aug 19, 2026 | Aguilar Moses Victor Javier Chf Rsch, Dev & Innov Officer | Sale | 3,053 | $439.0K |
| Aug 19, 2026 | Raman Sundar G. CEO-Fabric Home & Habitat Care | Award | 9,285 | $0 |
| Aug 19, 2026 | Santos de Azevedo Juliana Monteiro CEO - Grooming | Award | 6,497 | $0 |
| Aug 19, 2026 | Schulten Andre Chief Financial Officer | Award | 14,460 | $0 |
| Aug 19, 2026 | Purushothaman Balaji Chief Human Resources Officer | Award | 4,787 | $0 |
| Aug 19, 2026 | Jejurikar Shailesh Chairman, President and CEO | Award | 16,195 | $0 |
| Aug 19, 2026 | Bharucha Freddy P. CEO - Beauty | Award | 837 | $0 |
| Aug 19, 2026 | Aguilar Moses Victor Javier Chf Rsch, Dev & Innov Officer | Award | 6,839 | $0 |
| Aug 19, 2026 | Abd El Hak Hesham CEO-Baby and Feminine Care | Award | 5,129 | $0 |
| Aug 19, 2026 | Janzaruk Matthew W. SVP - Chief Accounting Officer | Award | 515 | $0 |
| Aug 19, 2026 | Gama Paul CEO- Health Care | Award | 7,727 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for PROCTER & GAMBLE Co
Free account. Everything above stays public.
Write why you follow PROCTER & GAMBLE Co and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading
Other companies in Consumer Staples
Nearest to Procter & Gamble by market cap among the sector's top 20 companies at Q2 2026.